Antibody Discovery Market

Antibody discovery is the process of identifying and discovering new types of antibodies to fight different types of diseases such as HIV, and other types of hereditary diseases. The technology using antibodies to treat diseases has revolutionized the industry of laboratories which seeks out in finding drugs for the treatment of the diseases. The most important method for the treatment of diseases such as inflammation, cancer, and other various diseases is the application of monoclonal antibodies.

Antibody drugs are proven to be the best treatment for a wide range of diseases. Monoclonal antibodies therapies provide a wide range of advantages as compared to traditional therapy such as chemotherapy and radiotherapy. The antibodies are of two types is monoclonal antibodies and polyclonal antibodies. The development of vaccines and drugs to fight the COVID-19 pandemic is an example of this market.

Market Scope and Structure Analysis:

Impact of COVID-19 on Antibody Discovery Market

At the early phase of the COVID-19, there was no availability of specific diagnostic tests to detect the disease in patients. Alternative diagnostic tests were used initially but were not much effective. This unavailability of specific COVID-19 diagnostic tests presented lucrative opportunities for diagnostic manufacturers to introduce their COVID-19 diagnostic kits. Many leading players as well as some start-ups from various countries utilized this opportunity and introduced COVID-19 diagnostics kits into local as well as global markets. These players achieved an edge over other diagnostics players capitalizing on the opportunity from demand for COVID-19 diagnostic tests, which, in turn, helped them in maintaining their revenues in such a crisis. Owing to such factors, COVID 19 is expected to have a significant impact on the antibody discovery market.

COVID-19 is an infectious disease caused by a newly discovered novel coronavirus. Which was not known to us before the outbreak in Wuhan (China) in December 2019. COVID-19 has moved from a regional crisis to a global epidemic in just a few weeks. So, the need for antibodies is a must and this market is not only required right now but also in the future as we do not know what kind of new diseases and viruses will be discovered in the future. The antibody discovery market should also be technologically advanced so that we can counter the undiscovered viruses and develop antibodies before the outbreak.

Top Impacting Factors: Market Scenario Analysis, Trends, Drivers, and Impact Analysis

• The antibody discovery market has been growing significantly as the number of diseases increases. The newly discovered diseases and viruses such as HIV, COVID-19 drive the market growth of the antibody discovery market. The development of antibodies to fight the diseases has been one of the most important concerns such as the ongoing pandemic, the development of new drugs as well as new vaccines to counter the COVID-19 is one of the major concerns of most pharmaceutical and biotechnological companies.
• The increasing development in the healthcare sector, development in research and development, increase in expenditure in the healthcare sector, as well as the discovery of different types of diseases, drive the market growth for the antibody discovery market. With the increase in the development of new diseases, the number of monoclonal antibodies that have been approved to date is close to 80 as well as more than 550 molecules in the clinical pipeline. Monoclonal antibody therapy has been the most important part of the biopharmaceutical industry.
• The factors that hinder the growth of the market include the high cost of research and development of discovering drugs and therapies for different kinds of diseases, the discovery of antibodies takes a lot of time even though there is a technological advancement in the market and the newly developed antibodies do not guarantee the 100% treatment of diseases, for example, the newly developed vaccines for COVID-19 which took almost 1 and half year to develop does not guarantee the treatment and cure for COVID-19.

Market Trends:

Twist Bioscience Corporation collaborated with MOLCURE AI Technology to Augment Therapeutic Antibody Discovery on July 26, 2021. Both the companies (Twist Bioscience Corporation and MOLCURE) have collaborated to discover and find new antibodies.

Paragon Therapeutics announces an antibody discovery joint venture with FairJourney Biologics on July 20, 2021. This joint venture will fuel the pipeline for the best antibody therapies.

Key Benefits of the Report:

• This study presents the analytical depiction of the antibody discovery market along with the current trends and future estimations to determine the imminent investment pockets.
• The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the antibody discovery market share.
• The current market is quantitatively analyzed from 2020 to 2030 to highlight the antibody discovery market growth scenario.
• Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
• The report provides a detailed antibody discovery market analysis based on competitive intensity and how the competition will take shape in coming years

Questions Answered in the Antibody Discovery Market Report:

• Who are the leading players active in the antibody discovery market?
• What are the current trends that will influence the market in the next few years?
• What are the driving factors, restraints, and opportunities of the market?
• What future projections would help in taking further strategic steps?
• What is "antibody discovery"?
• What is "antibody discovery” market prediction in the future?

 Antibody Discovery Market Report Highlights